TR
Thappali Ramaswamy Sethuraman Satheesh Manikandan
About Thappali Ramaswamy Sethuraman Satheesh Manikandan
Data last updated:
Thappali Ramaswamy Sethuraman Satheesh Manikandan is a Director at Fenix Research Labs Private Limited (since 2022) and Director at Sirak Pharmaceuticals Private Limited (since 2022). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹14.58 Cr; the largest is Fenix Research Labs Private Limited at ₹11.62 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 26 Aug 2022 | 2008 | ₹11.62 Cr (FY 2025) | Active | |
| Director | 31 Mar 2022 | 2008 | ₹2.97 Cr (FY 2024) | Active |
Board colleagues of Thappali Ramaswamy Sethuraman Satheesh Manikandan
| Name | DIN | Company | Designation |
|---|---|---|---|
| Pranav Chirayu Amin | 00245099 | Fenix Research Labs Private Limited | Director |
| Satya Kameswari Vakkalanka | 01544061 | Fenix Research Labs Private Limited , Sirak Pharmaceuticals Private Limited | Director |
| Shaunak Chirayu Amin | 00245523 | Fenix Research Labs Private Limited | Director |
| Sita Samyukta Vakkalanka | 08947205 | Sirak Pharmaceuticals Private Limited | Director |
| Swaroopkumar Venkata Satya Vakkalanka | 01737384 | Sirak Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Thappali Ramaswamy Sethuraman Satheesh Manikandan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Thappali Ramaswamy Sethuraman Satheesh Manikandan
Thappali Ramaswamy Sethuraman Satheesh Manikandan currently holds 2 directorships: Fenix Research Labs Private Limited (Director, since 26 Aug 2022, revenue ₹11.62 Cr (FY 2025)); Sirak Pharmaceuticals Private Limited (Director, since 31 Mar 2022, revenue ₹2.97 Cr (FY 2024)).
Thappali Ramaswamy Sethuraman Satheesh Manikandan was first appointed on 31 Mar 2022 as Director at Sirak Pharmaceuticals Private Limited.
The 2 current companies of Thappali Ramaswamy Sethuraman Satheesh Manikandan that report revenue have a combined latest revenue of ₹14.58 Cr: Fenix Research Labs Private Limited ₹11.62 Cr (FY 2025); Sirak Pharmaceuticals Private Limited ₹2.97 Cr (FY 2024).
The current boards of Thappali Ramaswamy Sethuraman Satheesh Manikandan's companies include Pranav Chirayu Amin (Fenix Research Labs Private Limited), Satya Kameswari Vakkalanka (Fenix Research Labs Private Limited), Shaunak Chirayu Amin (Fenix Research Labs Private Limited), Sita Samyukta Vakkalanka (Sirak Pharmaceuticals Private Limited), Swaroopkumar Venkata Satya Vakkalanka (Sirak Pharmaceuticals Private Limited).